[Left-sided endocarditis due to gram-negative bacilli: epidemiology and clinical characteristics]

Enferm Infecc Microbiol Clin. 2011 Apr;29(4):276-81. doi: 10.1016/j.eimc.2010.12.007. Epub 2011 Feb 22.
[Article in Spanish]

Abstract

Introduction: The aim of this study is to describe the epidemiological, clinical characteristics, and outcome of patients with left-side endocarditis caused by gram-negative bacteria.

Method: Prospective multicenter study of left-sided infective endocarditis reported in the Andalusian Cohort for the Study of Cardiovascular Infections between 1984 and 2008.

Results: Among the 961 endocarditis, 24 (2.5%) were caused by gram-negative bacilli. The most common pathogens were Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica. Native valves (85.7%) were mainly affected, most of them with previous valve damage (57%). Comorbidity was greater (90% vs 39%; P=.05) than in endocarditis due to other microorganism, the most frequent being, diabetes, hepatic cirrhosis and neoplasm. A previous manipulation was found in 47.6% of the cases, and 37% were considered hospital-acquired. Renal failure (41%), central nervous system involvement (33%) and ventricular dysfunction (45%) were the most frequent complications. Five cases (21%) required cardiac surgery, mostly due to ventricular dysfunction. More than 50% of cases were treated with aminoglycosides, but this did not lead to a better outcome or prognosis. Mortality (10 patients) was higher than that reported with other microorganisms (41% vs 35%; P=.05).

Conclusions: Left-sided endocarditis due to gram-negative bacilli is a rare disease, which affects patients with major morbidities and often with a previous history of hospital manipulations. Cardiac, neurological and renal complications are frequent and associated with a high mortality. The association of aminoglycosides in the antimicrobial treatment did not involve a better outcome or prognosis.

Publication types

  • English Abstract
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / etiology
  • Anti-Bacterial Agents / therapeutic use
  • Combined Modality Therapy
  • Comorbidity
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Diabetes Complications / epidemiology
  • Diabetes Complications / microbiology
  • Endocarditis, Bacterial / complications
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / epidemiology*
  • Endocarditis, Bacterial / microbiology
  • Endocarditis, Bacterial / surgery
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / epidemiology*
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Negative Bacterial Infections / surgery
  • Heart Failure / etiology
  • Heart Valve Diseases / epidemiology
  • Heart Valve Diseases / surgery
  • Heart Valve Prosthesis Implantation
  • Humans
  • Liver Cirrhosis / epidemiology
  • Neoplasms / epidemiology
  • Prospective Studies
  • Spain / epidemiology
  • Ventricular Dysfunction, Left / etiology

Substances

  • Anti-Bacterial Agents